India has unveiled a national pathogen surveillance network to combat antimicrobial resistance (AMR), a growing public health crisis. The initiative aims to track drug-resistant infections, guide antibiotic use, and improve hospital reporting—marking a major step in the country’s fight against deadly superbugs.
India’s New Pathogen Strategy Targets AMR Crisis
In response to rising antimicrobial resistance, India has launched a national pathogen surveillance system designed to monitor drug-resistant infections and improve treatment protocols. The initiative integrates hospital data, lab diagnostics, and genomic sequencing to identify emerging threats and guide antibiotic stewardship.
According to recent health data, over 1 million Indians were infected with carbapenem-resistant bacteria in 2021 alone. The new framework aims to reduce antibiotic misuse, which currently sees 80% of full courses procured but only 7.8% of estimated cases treated effectively. The system aligns with WHO’s global AMR strategy and positions India as a proactive player in global health governance.
Major takeaways
-
India launches national pathogen surveillance network to fight AMR
-
Over 1 million drug-resistant infections reported in 2021
-
System to track hospital data, lab results, and genomic trends
-
Aims to reduce antibiotic misuse and improve treatment outcomes
-
Supports WHO’s global AMR strategy
Sources: India Today, Indian Express, The Hindu, The Science World, Economic Times, Moneycontrol, ScanX News